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ABSTRACT
Introduction: The term ‘‘predisposing heart
condition’’ is used as an indication of
antimicrobial prophylaxis to prevent infective
endocarditis (IE) and as a criterion for
diagnosing IE according to modified Duke
criteria. The purpose of this survey was to
elaborate clinician’s knowledge and opinion
on relevant heart conditions as a Duke minor
criterion for the diagnosis of IE.
Methods: A questionnaire was created that
consisted of two knowledge and two opinion
questions on the term predisposing heart
condition. The survey included results from
318 questionnaires with responses from
specialists in the field of internal medicine,
infectious diseases, and cardiology.
Results: The answers of what participants
believed to be currently a Duke minor
criterion and what they thought should be
minor criterion were very distributed with a
median accordance of 33%.
Conclusion: The survey indicates that there is
significant uncertainty regarding what is
encountered as a Duke minor criterion
predisposing heart condition in a native valve.
Keywords: Endocarditis; Risk assessment;
Valvular heart disease
INTRODUCTION
The original concept of antibiotic prophylaxis
for infective endocarditis (IE) led to the
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recommendation for antimicrobial agents in a
large number of patients with predisposing
cardiac conditions who were undergoing a
wide range of procedures. In the following
years, indications for antibiotic prophylaxis
were restricted and the populations at risk
defined. These populations included (1)
patients with any prosthetic valve, including a
transcatheter valve, or those in whom any
prosthetic material was used for cardiac valve
repair; (2) patients with a previous episode of
IE; and (3) patients with congenital heart
disease (CHD). The last group consists of two
subcategories: (a) those with any type of
cyanotic CHD and (b) those with any type of
CHD that has been repaired with prosthetic
material, whether placed surgically or by
percutaneous techniques, up to 6 months after
the procedure or for the patient’s lifetime if a
residual shunt or valvular regurgitation remains
[1]. In the modified Duke criteria, on the other
hand, a ‘‘predisposing heart condition’’ is a
minor criterion for diagnosing IE. In cases of
suspected IE but negative imaging results, this
criterion may become relevant for forming the
diagnosis. Thus, the same term (predisposing
heart condition) is used as an indication of
antimicrobial prophylaxis to prevent IE and as
a criterion for diagnosing IE. However, whereas
the use of the term for antimicrobial
prophylaxis is (meanwhile) well defined, the
criterion for diagnosing IE is not. In our
experience, clinicians consider a larger
number of heart conditions as a minor
criterion for the diagnosis of IE than they use
for the prevention of IE [2]. Therefore, we
performed a survey to address this impression.
The aim of our survey was to elaborate on the
knowledge and opinion of clinicians on the
applicability of the minor criterion of a
predisposing heart condition in native valves
for the diagnosis of IE.
METHODS
A questionnaire (Supplemental Material S1) was
designed and tested to be completed within
5 min. It included questions about training,
degrees, and clinical experience of study
participants, as well as two knowledge and two
opinion questions. Nineteen departments in 13
different institutions within Switzerland were
visited to perform the survey (see
‘‘Acknowledgements’’). Questionnaires were
distributed at morning meetings and directly
collected afterwards. All questionnaires were
filled out anonymously. A sample size of 300 was
targeted prior to the study. Participants included
either physicians undergoing postgraduate
education and specialization, or specialists in the
fields of internal medicine, infectious diseases, or
cardiology. Answers were independently
evaluated by two members of the study team
(A.B. and P.S.) and categorized as acceptable (wide
range of answers) or definitely wrong (narrow
range of answers, Supplemental Material S2). The
rational to accept a wide range of answers relied on
the fact that the term ‘‘predisposing heart
condition’’ in native valves is not well defined;
thus, for many answers it was scientifically
difficult to categorize them as definitely wrong.
In case of disagreement, a third member of the
study team was involved and the decision was
made by the majority. Accordance between
knowledge and opinion was analyzed and
illustrated in a bi-directional graph. For this
analysis, foreign body material was excluded
because the focus in the opinion question was
on native valves, while ‘‘foreign body material’’
was a correct answer in the knowledge question.
GraphPad Prism 5.0 was used for statistical
analysis. Differences in group proportions were
assessed by contingency tables and the Chi-square
test, or by Fisher’s exact probability test if cell
values were less than 5. The Student’s t test was
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applied where appropriate. A two-tailed p value of
0.05 or less was considered significant.
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
2013. Informed consent was obtained from all
patients for being included in the study.
RESULTS
Study Participants
In total, 318 questionnaires were collected. We
included all of them in the analysis because the
completion rate was more than 90%. Less than 5%
of the participants had 1–2 years of clinical
experience, 19.2% had 2–5 years of experience,
and 75.7% had more than 5 years of clinical
experience at the time of the survey. Most
participants (52%) worked at a secondary care
center, 35% at a university hospital (tertiary
referral center), and 13% at a regional hospital or
in a private practice. The participating centers are
listed in the ‘‘Acknowledgements’’. Half of the
participants were in postgraduate training for a
medical speciality. Of the responders, 31.8% had a
double specialization (e.g., internal medicine and
cardiology) and 12.9% were undergoing
postgraduate training for their second
specialization. The majority of participants
(61.5%) completed training in general internal
medicine. Other frequent specialities included
infectious diseases and cardiology. In 91.2% of the
responders diagnosis and treatment of IE is part of
their routine clinical work.
Questionnaire Answers
Participants were asked whether or not the
Duke minor criterion, ‘‘predisposing heart
condition’’, is precisely defined in either the
European or the American guidelines for IE.
Although it is not precisely defined, 54
participants (17.3%) answered yes, 83 (26.6%)
answered no, and 175 (56.1%) indicated that
they did not know the answer.
Participants were asked what—to their
knowledge—a predisposing heart condition is
for the diagnosis of IE according to the modified
Duke criteria. The most frequent answers are
reflected in Table 1. Forty-five participants
(14.2%) indicated at least one wrong answer.
The proportion of wrong answers did not differ
between the specialties (internal medicine
14.2%, cardiology 15.7%, infectious diseases
14.3%, other 15.8%). Similar findings were
found when appointment levels were
compared for at least one wrong answer
(registrars 15.3%, consultants 13.5%, lead
physicians 14.3%, and head of departments
11.8%). There was an inverse association
between wrong answers and number of years
of clinical experience. Thirty percent (30%) of
physicians with 1–2 years of experience
indicated a least one wrong answer. In doctors
with 3–5 years of clinical experience, this
proportion was 11.7%, and in doctors with
more than 5 years of clinical experience it was
14.3% (p = 0.02).
Participants were also asked what—in their
opinion—a predisposing heart condition
should constitute as a minor criterion for the
diagnosis of IE. Although a wide range of
answers was given, there was no congruence
between knowledge and opinion for the vast
majority of the answers (Table 1). The median
accordance of the answers to knowledge
(question II.1) and opinion (question II.3) for
each participant was 33% (SD 38.84%) (Fig. 1).
Finally, participants were then presented with a
case–control study published in 1982 [3],
showing that mitral valve prolapse (MVP) was
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Table 1 Frequency of responses to knowledge and opinion questions
Condition Knowledge question (%) Opinion question (%)
Foreign body material 67 –a
Prior infective endocarditis 32.4 22.9
Valvular vitium 26.1 11.8
Grown-up congenital heart disease 19.0 8.8
Vitium (not speciﬁed) 16.3 7.7
Shunt 15.7 13.1
Bicuspid aortic valve 12.7 29.0
Mitral valve insufﬁciency 12.7 32.3
Mitral valve prolapse 12.1 32.3
Aortic valve stenosis 11.4 31.0
Aortic valve insufﬁciency 10.1 20.5
Rheumatic heart disease 9.2 12.5
Mitral valve stenosis 8.8 26.6
Cyanotic heart disease 8.2 4.4
Tricuspid valve insufﬁciency 8.2 17.8
Pulmonary valve insufﬁciency 6.5 13.5
Tricuspid valve stenosis 5.6 14.5
Degenerative valve disease 5.2 0
Pulmonary valve stenosis 4.6 13.5
Cardiac surgery (without foreign body material) 3.9 4.4
Heart failure 3.3 2.4
Heart transplant 2.9 1.7
Signiﬁcant turbulence 2.6 2.7
Hypertrophic obstructive cardiomyopathy 1.3 9.1
Dilatative cardiomyopathy 0.3 1.0
Prior myocardial infarction/coronary heart disease 0 1.3
Thrombus 0 0.7
Arrhythmias 0 0.7
Endothelial damage 0 1.0
Low ﬂow 0 0.3
Paravalvular leakage 0 0.3
Cardiol Ther
associated with a higher risk for IE (odds ratio
8.2; 95% CI 2.4–28.4). Almost two-thirds of the
responders indicated that they would not
expect similar results if the study were to be
repeated today, either because MVP criteria are
different from those used in 1982, or because
the echocardiographic technique used today is
better than it was in 1982, and thus MVP was
previously overdiagnosed.
DISCUSSION
Over the past years, a predisposing heart
condition that would put a patient at risk for
IE, thus justifying antimicrobial prophylaxis,
has been narrowed down to four defined
entities. In parallel, diagnostic imaging
methods have been improved, and repeated
echocardiography for the diagnosis of IE is
recommended. Moreover, imaging criterion
can be fulfilled by diagnostic means other
than echocardiography, including 18F-FDG/
PET CT, radiolabelled leukocytes SPECT/CT,
and cardiac CT [1, 4]. Nonetheless, the Duke
criterion of a predisposing heart condition is
poorly defined, in particular for native valves
with no history of previous IE. In our survey,
the range of answers regarding the nature of a
predisposing heart condition was very broad
(Table 1). This diagnostic uncertainty may lead
to overdiagnosis of IE in patients with positive
results of blood cultures (e.g.,
non-staphylococcal bacteremia) but
inconclusive imaging results. Nonetheless, in
the early phase of disease and suspicion of IE, it
may be prudent to overdiagnose disease and
perform echocardiography [5]. In the longer
course of the disease, however, overtreatment of
IE contributes to development of resistance of
organisms in the microbiome and is associated
with adverse events of antimicrobial agents [6].
An unprecise Duke minor criterion is, in our
view, not helpful in the decision-making for or
against the final diagnosis of IE.
The answers regarding what participants
believed is true (knowledge question) and
what they felt should be true (opinion
question) were not similar on many of the
questionnaires. On the one hand, these results
may underline the difficulty in diagnosing IE in
clinical practice, and on the other, they may
point towards uncertainty in how to interpret
and apply the Duke minor criterion of a
predisposing heart condition. We only found
an association between the wrong answers (very
narrowly defined, Supplementary Material S2)
with less than 3 years of clinical experience.
Two-thirds of the participants were
convinced that in previous years, the diagnosis
of MVP was overestimated. If this is true, a
certain proportion of patients was falsely
postulated to be at risk for IE. This again may
have influenced the statistical risk stratification.
A repetition of this study with current
diagnostic methods may help to answer this
question.
Table 1 continued
Condition Knowledge question (%) Opinion question (%)
Tumor 0 0.3
Participants were asked what they ‘‘knew’’ was a predisposing heart condition for infective endocarditis (knowledge question)
and what they felt should be listed as a predisposing heart condition (opinion questions). Results are presented in frequency
percentages (%) of the total number of answers
a The question focussed in particular on native valves
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Our survey does not provide final results
other than to show that there is a trend for
uncertainty regarding what is encountered as a
Duke minor criterion predisposing heart
condition in a native valve. In our view, it is
reasonable to encounter anatomical variants
that cause significant turbulence and may be a
risk factor when IE is suspected at first clinical
presentation. However, over a 2-week period,
the clinical course, microbiological criteria, and
repeated imaging with modern techniques
should allow confirmation or rejection of the
definite diagnosis of IE in the majority of cases,
irrespective of the presence of valve disease.
Our survey has limitations. It includes a
selection bias of participants, because only
physicians present at morning meetings at the
date of investigation filled out the
questionnaire. Although the questionnaire was
tested on several occasions, it was not validated
prior to the study.
CONCLUSION
Our survey shows that in clinical practice there
is uncertainty regarding what is encountered as
a Duke minor criterion predisposing heart
condition in a native valve. As has been done
for the term ‘‘predisposing heart condition’’
with respect to antimicrobial prophylaxis, a
more precise definition for diagnosis of IE
would be helpful. A meta-analysis
investigating the statistical association
between predisposing heart conditions in
native valves and IE is currently being
performed.
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